GenoTech (Pharmaceutical Materials Division) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

GenoTech (Pharmaceutical Materials Division) General Information

Description

Producer of pharmaceutical raw materials intended for antibiotics and immunosuppressants.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Jecheon
  • South Korea
Primary Industry
Pharmaceuticals
Acquirer
Ceres F&D
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Jecheon
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenoTech (Pharmaceutical Materials Division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenoTech (Pharmaceutical Materials Division)‘s full profile, request access.

Request a free trial

GenoTech (Pharmaceutical Materials Division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenoTech (Pharmaceutical Materials Division)‘s full profile, request access.

Request a free trial

GenoTech (Pharmaceutical Materials Division) FAQs

  • Where is GenoTech (Pharmaceutical Materials Division) headquartered?

    GenoTech (Pharmaceutical Materials Division) is headquartered in Jecheon, South Korea.

  • What industry is GenoTech (Pharmaceutical Materials Division) in?

    GenoTech (Pharmaceutical Materials Division)’s primary industry is Pharmaceuticals.

  • Is GenoTech (Pharmaceutical Materials Division) a private or public company?

    GenoTech (Pharmaceutical Materials Division) is a Private company.

  • What is the current valuation of GenoTech (Pharmaceutical Materials Division)?

    The current valuation of GenoTech (Pharmaceutical Materials Division) is .

  • What is GenoTech (Pharmaceutical Materials Division)’s current revenue?

    The current revenue for GenoTech (Pharmaceutical Materials Division) is .

  • Who are GenoTech (Pharmaceutical Materials Division)’s investors?

    GenoTech has invested in GenoTech (Pharmaceutical Materials Division).

  • When was GenoTech (Pharmaceutical Materials Division) acquired?

    GenoTech (Pharmaceutical Materials Division) was acquired on 14-Aug-2018.

  • Who acquired GenoTech (Pharmaceutical Materials Division)?

    GenoTech (Pharmaceutical Materials Division) was acquired by Ceres F&D.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process